ICD-10-CM Billable Code

H11.029

Central pterygium of unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Central pterygium of the eye is a benign growth of tissue that occurs on the conjunctiva, the clear tissue covering the white part of the eye. This condition typically develops on the nasal side (closest to the nose) but can extend towards the cornea, the eye’s transparent front surface. When referred to as 'central', it indicates that the growth is located in the central area of the eye's surface. The condition is generally non-cancerous and can affect vision if it grows over the cornea. Diagnosis is made through eye examination, and treatment options vary based on the size and severity of the growth.

Causes & Symptoms

Clinical Causes: Excessive exposure to sunlight, wind, or dust Chronic eye irritation or dryness Prolonged exposure to ultraviolet (UV) radiation Genetic predisposition or family history History of eye trauma or injury Environmental factors such as pollution

Key Symptoms: A pinkish, fleshy growth on the surface of the eye A visible, translucent or pinkish tissue encroaching onto the cornea Irritation, redness, or a sensation of dryness in the affected eye Blurry vision if the growth extends onto the cornea A feeling of having a foreign body in the eye In some cases, no symptoms are present, and the growth is found during routine eye exams

Diagnostic & Treatment

Diagnosis Path: use special dyes or imaging techniques if necessary to evaluate the effect of the pterygium on the cornea.

Treatment Protocols: Observation and regular monitoring if the growth is small and asymptomatic Use of lubricating eye drops or ointments to alleviate dryness and irritation Protection from environmental factors such as UV rays by wearing sunglasses with UV protection Surgical removal if the pterygium causes significant discomfort, visual impairment, or cosmetic concerns. The procedure involves excising the abnormal tissue and may include adjunctive therapies to reduce the risk of recurrence. Postoperative care typically involves eye drops to prevent infection and promote healing.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H11.029 a billable ICD-10 code?
Yes, H11.029 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H11.029?
Clinical documentation must specify the nature of Central pterygium of unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference